Armodafinil 250 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DX25F6TYJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,911
Award facts
- Contract value 100% obligated
- $2,910.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Armodafinil 250 mg tablets (30-count) under a firm fixed-price contract with a ceiling value of $2,910.87. This non-set-aside, competitively awarded delivery order is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999.99 billion prime vendor agreement extending through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to fulfill federal medical supply requirements across multiple therapeutic domains. This particular delivery order for Armodafinil, a wakefulness-promoting agent commonly used in military and veteran healthcare settings, exemplifies the routine pharmaceutical procurement executed through the company's established DLA prime vendor vehicle.
Quick answers
Who was awarded contract SPE2DX25F6TYJ?
SPE2DX25F6TYJ was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 26, 2025.
How much is contract SPE2DX25F6TYJ worth?
The government has obligated $2,911 on SPE2DX25F6TYJ.
Is contract SPE2DX25F6TYJ an order under another contract?
Yes. SPE2DX25F6TYJ is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6TYJ competed?
The extent of competition for SPE2DX25F6TYJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award